Pivmecillinam hydrochloride

Pivmecillinam hydrochloride (CAS No.: 32887-03-9) is a synthetic small molecule classified as a beta lactam antibacterial research agent and as the orally active prodrug form of mecillinam, commonly positioned in anti infective discovery programs focused on Gram negative organisms and cell wall biology. In biochemical and microbiological research contexts, its functional background is linked to conversion to mecillinam, which shows preferential interaction with penicillin binding protein 2 in susceptible bacteria, thereby disrupting peptidoglycan assembly, altering rod shape maintenance, and promoting loss of cell wall integrity through pathways associated with bacterial elongation and division machinery. Consistent with this class mechanism, reported in vitro potency is generally discussed using susceptibility endpoints such as MIC values that vary by strain and assay conditions and are commonly interpreted from low to moderate concentration ranges in standard antimicrobial testing rather than as single universal constants, while direct mammalian signaling pathway modulation is not regarded as its primary mode of action. The compound is therefore mainly used as a reference or comparator in microbiology assays, resistance mechanism studies, beta lactam pharmacology investigations, and screening workflows evaluating antibacterial combinations, spectrum shifts, and structure activity trends in Gram negative focused panels, with additional use in translational preclinical infection models where exposure selection is protocol dependent; the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.